The pharmaceutical industry is engaging in a flurry of biotech deals and shifting clinical trials to China. It does so at a time when the U.S. is distancing from China.
Fierce’s Rebecca Willumson sat down with Swoop President Scott Rines – live at Digital Pharma East – to discuss some of the most pressing issues in pharma marketing today. Rines kicks off by debunking ...
Traws Pharma, Inc. (TRAW) has disclosed a new risk, in the Corporate Activity and Growth category. The integration of Onconova and Trawsfynydd poses a significant risk to Traws Pharma, Inc.’s future ...
It’s a historic day for drug pricing: the Biden administration officially announced the final prices of the first 10 drugs chosen to be a part of the Medicare drug negotiation program under the ...
The integration of cannabinoids into mainstream pharmaceutical practices has been a topic of significant debate and interest over the past decade. As scientific research continues to unravel the ...
Pharma marketers frequently cite the need to craft marketing that’s rooted in empathy. For Katie Williams, chief marketing officer (CMO) at GSK’s consumer health spinoff Haleon, empathy manifests as ...
LITTLETON, Colo. and CHICAGO, June 3, 2025 /PRNewswire/ -- DeFloria, Inc., the botanical-drug developer advancing the first of its kind AJA001 oral solution for autism spectrum disorder (ASD), today ...
This article was written for and originally appeared in Issue 19 December 2024, of The Receiver, a publication of the National Association of Federal Equity Receivers (NAFER), and is being reproduced ...
Plants are quietly borrowing tricks from bacteria, repurposing foreign genes to build complex molecules that look a lot like tomorrow’s medicines. By turning leaves and cultured cells into ...
Shawn Patrick O’Brien stepped down as CEO and managing director, and Aaron Gray, currently Mayne Pharma’s chief financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results